BRPI0915947A2 - uso de idrabiotarapinux para diminuição da incidência de sangramentos durante tratamento antitrombótico - Google Patents
uso de idrabiotarapinux para diminuição da incidência de sangramentos durante tratamento antitrombóticoInfo
- Publication number
- BRPI0915947A2 BRPI0915947A2 BRPI0915947-9A BRPI0915947A BRPI0915947A2 BR PI0915947 A2 BRPI0915947 A2 BR PI0915947A2 BR PI0915947 A BRPI0915947 A BR PI0915947A BR PI0915947 A2 BRPI0915947 A2 BR PI0915947A2
- Authority
- BR
- Brazil
- Prior art keywords
- idrabiotarapinux
- reduce bleeding
- treatment
- antithrombotic treatment
- incidence during
- Prior art date
Links
- 208000032843 Hemorrhage Diseases 0.000 title abstract 4
- 208000034158 bleeding Diseases 0.000 title abstract 4
- 230000000740 bleeding effect Effects 0.000 title abstract 4
- 230000002785 anti-thrombosis Effects 0.000 title abstract 2
- 239000003146 anticoagulant agent Substances 0.000 title abstract 2
- MUQWDYYIYNYBQD-OFHININYSA-N (2s,3s,4s,5r,6r)-3-[(2r,3r,4r,5s,6r)-3-[6-[5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoylamino]-4,5-dimethoxy-6-(sulfooxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-6-[(2r,3s,4s,5r,6r)-2-carboxy-4,5-dimethoxy- Chemical compound OS(=O)(=O)O[C@@H]1[C@@H](OS(O)(=O)=O)[C@@H](OC)O[C@H](COS(O)(=O)=O)[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@@H]2[C@@H]([C@@H](OS(O)(=O)=O)[C@H](O[C@H]3[C@@H]([C@@H](OC)[C@H](O[C@@H]4[C@@H]([C@@H](OC)[C@H](OC)[C@@H](COS(O)(=O)=O)O4)NC(=O)CCCCCNC(=O)CCCC[C@H]4[C@H]5NC(=O)N[C@H]5CS4)[C@H](O3)C(O)=O)OC)[C@@H](COS(O)(=O)=O)O2)OS(O)(=O)=O)[C@H](C(O)=O)O1 MUQWDYYIYNYBQD-OFHININYSA-N 0.000 abstract 3
- 208000007536 Thrombosis Diseases 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000009863 secondary prevention Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyridine Compounds (AREA)
Abstract
uso de idrabiotaparinux para diminuição da incidência de sangramentos durante tratamento anti-trombótico a presente invenção refere-se ao uso de idrabiotaparinux para o tratamento e prevenção secundária de patologias trombóticas, em que o uso de idrabiotaparinux implica uma diminuição da incidência de sangramentos, em particular sangramentos graves, durante esse tratamento.
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08290704A EP2145624A1 (en) | 2008-07-18 | 2008-07-18 | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| EP08290704.9 | 2008-07-18 | ||
| EP09290216A EP2233143A1 (en) | 2009-03-24 | 2009-03-24 | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
| EP09290216.2 | 2009-03-24 | ||
| PCT/IB2009/006621 WO2010007530A1 (en) | 2008-07-18 | 2009-07-17 | Use of idrabiotaparinux for decreasing the incidence of bleedings during an antithrombotic treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0915947A2 true BRPI0915947A2 (pt) | 2019-04-09 |
Family
ID=41203891
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0915947-9A BRPI0915947A2 (pt) | 2008-07-18 | 2009-07-17 | uso de idrabiotarapinux para diminuição da incidência de sangramentos durante tratamento antitrombótico |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US20110245200A1 (pt) |
| EP (1) | EP2315593A1 (pt) |
| JP (1) | JP2011528345A (pt) |
| KR (1) | KR20110044747A (pt) |
| CN (1) | CN102149389A (pt) |
| AR (1) | AR072520A1 (pt) |
| AU (1) | AU2009272373A1 (pt) |
| BR (1) | BRPI0915947A2 (pt) |
| CA (1) | CA2730975A1 (pt) |
| IL (1) | IL210692A0 (pt) |
| MX (1) | MX2011000673A (pt) |
| RU (1) | RU2011106037A (pt) |
| TW (1) | TW201006479A (pt) |
| UY (1) | UY31995A (pt) |
| WO (1) | WO2010007530A1 (pt) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2721044B1 (en) * | 2011-06-17 | 2015-11-18 | Carbomimetics | Synthetic pentasaccharides having short half-life and high activity |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2814463B1 (fr) * | 2000-09-22 | 2002-11-15 | Sanofi Synthelabo | Nouveaux polysaccharides a activite antithrombotique comprenant au moins une liaison covalente avec la biotine ou un derive de la biotine |
| FR2874924B1 (fr) * | 2004-09-09 | 2006-12-01 | Sanofi Aventis Sa | Hexadecasaccharides biotinyles, leur preparation et leur utilisation therapeutique |
| MY145269A (en) * | 2005-10-10 | 2012-01-13 | Organon Nv | Antithrombotic dual inhibitors comprising a biotin label |
-
2009
- 2009-07-16 TW TW098124139A patent/TW201006479A/zh unknown
- 2009-07-17 BR BRPI0915947-9A patent/BRPI0915947A2/pt not_active IP Right Cessation
- 2009-07-17 RU RU2011106037/15A patent/RU2011106037A/ru unknown
- 2009-07-17 MX MX2011000673A patent/MX2011000673A/es not_active Application Discontinuation
- 2009-07-17 KR KR1020117001141A patent/KR20110044747A/ko not_active Withdrawn
- 2009-07-17 JP JP2011518028A patent/JP2011528345A/ja active Pending
- 2009-07-17 US US13/003,623 patent/US20110245200A1/en not_active Abandoned
- 2009-07-17 AR ARP090102729A patent/AR072520A1/es not_active Application Discontinuation
- 2009-07-17 CA CA2730975A patent/CA2730975A1/en not_active Abandoned
- 2009-07-17 CN CN2009801352734A patent/CN102149389A/zh active Pending
- 2009-07-17 EP EP09786171A patent/EP2315593A1/en not_active Withdrawn
- 2009-07-17 UY UY0001031995A patent/UY31995A/es not_active Application Discontinuation
- 2009-07-17 WO PCT/IB2009/006621 patent/WO2010007530A1/en not_active Ceased
- 2009-07-17 AU AU2009272373A patent/AU2009272373A1/en not_active Abandoned
-
2011
- 2011-01-16 IL IL210692A patent/IL210692A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009272373A1 (en) | 2010-01-21 |
| RU2011106037A (ru) | 2012-08-27 |
| JP2011528345A (ja) | 2011-11-17 |
| MX2011000673A (es) | 2011-04-04 |
| IL210692A0 (en) | 2011-03-31 |
| TW201006479A (en) | 2010-02-16 |
| WO2010007530A1 (en) | 2010-01-21 |
| AR072520A1 (es) | 2010-09-01 |
| EP2315593A1 (en) | 2011-05-04 |
| US20110245200A1 (en) | 2011-10-06 |
| KR20110044747A (ko) | 2011-04-29 |
| CN102149389A (zh) | 2011-08-10 |
| UY31995A (es) | 2010-02-26 |
| CA2730975A1 (en) | 2010-01-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12014500075A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
| IN2012DN00624A (pt) | ||
| WO2010087964A3 (en) | Compositions for treatment and prevention of acne, methods of making the compositions, and methods of use thereof | |
| MX337990B (es) | Metodos para la prevencion y tratamiento de isquemia cerebral. | |
| WO2010023422A8 (en) | Use of prebiotic galacto-oligosaccharides in the treatment of intestinal inflammation | |
| WO2011053825A3 (en) | Compositions and methods for the treatment or prevention of mitochondrial diseases | |
| MX2009006536A (es) | Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales. | |
| UY32456A (es) | Composicion famaceutica, forma farmaceutica, procedimiento para su preparación, metodos de tratamiento | |
| MX2009009761A (es) | Composiciones y estuches para tratamiento de la influenza. | |
| MY172372A (en) | Compositions and methods for lowering triglycerides | |
| TNSN08400A1 (en) | Organic compounds and their uses | |
| WO2010036395A3 (en) | Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds | |
| TN2011000482A1 (en) | Organic compounds and their uses | |
| WO2007146983A3 (en) | Compositions comprising tegaserod alone or in combination with a proton pump inhibitor for treating or preventing gastric injury | |
| NZ597510A (en) | NOVEL ACETYLSALICYLIC ACID SALTS, the salts are 4-trimethylammoniobutanoate, L-carnitine and meldonium | |
| GB2482817A (en) | Novel use | |
| AU2009347008A8 (en) | Method of preventing diarrhoea | |
| WO2007144057A3 (en) | Antimicrobial carbon | |
| MX2014010940A (es) | El uso de antitrombina en el tratamiento de preeclampsia. | |
| EA200701820A1 (ru) | Применение диосметиновых соединений при лечении и профилактике тромботических патологий | |
| WO2010066346A3 (en) | Composition for the prevention and treatment of viral infections | |
| WO2010131038A3 (en) | Steroid containing composition and uses thereof | |
| MX2010004814A (es) | Metodos para tratar esclerodermia. | |
| WO2011041325A3 (en) | Methods and compositions for the treatment of viral disorders | |
| BRPI0915947A2 (pt) | uso de idrabiotarapinux para diminuição da incidência de sangramentos durante tratamento antitrombótico |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A, 7A, 8A E 9A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2519 DE 16-04-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |
|
| B350 | Update of information on the portal [chapter 15.35 patent gazette] |